Company Profile

Micronics Inc
Profile last edited on: 6/6/19      CAGE: 3ETH4      UEI:

Business Identifier: In vitro diagnostic products
Year Founded
1996
First Award
2004
Latest Award
2010
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8463 154th Avenue NE Building G
Redmond, WA 98052
   (425) 895-9197
   khedine@micronics.net
   www.micronics.net
Location: Single
Congr. District: 01
County: King

Public Profile

SInce 2011 functioning as a wholly owned subsiduary of Sony, Micronics, Inc. addresses near patient, point of care devices for disease diagnosis, treatment monitoring, and blood testing. A learly eader in development of fluid miniaturization solutions that integrate and automate laboratory processes on single use, disposable, versatile and cost-effective cartridges. integral to these solutions are Micronics’ core capabilities in microfluidics, surface chemistries, materials science and assay integration. The firm offered diagnostic products, including PanNAT Molecular Diagnostic System for infectious disease testing; and Immunohematology Diagnostic products that provide rapid tests for point of information blood typing. The company's immunohematology diagnostic products include ABORhCard that is developed to provide ABO and Rh blood type from a fingerstick blood sample; and ABO-Cross Match Card, a sample-to-result test developed to provide information about ABO compatibility between a transfusion recipient and a donor blood unit. It also provides research and development (R&D) products, including single-use, stand alone, and disposable microfluidics-enabled cartridges and microFlow integrated workstations. The company's R&D products include microFlow system, a low-pulse pump system that enables precise control of fluids in flow; Active Lab Cards for use with the microFlow system; and Access cards, a manually activated cards for the exploration of the principles of microfluidics in H-Filter and T-Sensor formats. Its R&D products enable researchers to develop assays, analyze fluids in flow, the evaluate compounds of interest in biological samples, and experiment broadly with microfluidics. In addition, the company offers custom design and development services, including prototype to commercial development of stand-alone disposable cartridges and integrated cartridge/instrument systems. It offers devices for sample preparation, antigen/antibody detection, DNA/RNA amplification, amplification-based detection of respiratory disease, and fluorescent and bead-based assays for soil and air sample analysis.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2010 2 NIH $871,595
Project Title: Rapid Point Of Care Hiv Pcr Diagnostic Device
2009 1 NIH $444,080
Project Title: Poc Molecular Method For Detection Of Known And Emerging Respiratory Viruses.
2006 1 NIH $99,979
Project Title: Microcytometer enrichment and detection of colon cancer*
2005 2 NIH $844,648
Project Title: Microfluidic Point-of-care Cancer Cell Analyzer

Key People / Management

  Karen Hedine -- President

  Charles "Fred" Battrell -- Chief Technology Officer

  John C Gerdes -- Chief Scientific Officer

  Larry Hambleton -- Vice President, Marketing and Sales

  Tim Patno -- Vice President, Product Development

  Reed Simmons -- Vice President, Manufacturing

  Manu Talwar -- Chief Financial Officer

  Diane Wierzbicki -- Vice President, Regulatory Affairs